Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Iron and multiple sclerosis.
The Olig family affects central nervous system development and disease.
Serum levels of melatonin and cytokines in multiple sclerosis.
Neurologic indications for therapeutic plasma exchange: 2013 update.
Autoantibodies in pre-clinical autoimmune disease.
Pituitary-ovary axis and ovarian reserve in fertile women with multiple sclerosis: A pilot study.
Comparative Effectiveness Using A Matching-Adjusted Indirect Comparison Between Delayed-Release Dimethyl Fumarate and Fingolimod for The Treatment of Relapsing-Remitting Multiple Sclerosis.
Robotic-Assisted Gait Training in Neurological Patients: Who May Benefit?
Cannabidiol, a non-psychoactive cannabinoid, leads to EGR2-dependent anergy in activated encephalitogenic T cells.
Impact of the environment on multiple sclerosis.
Epidemiology of aquaporin-4 autoimmunity and neuromyelitis optica spectrum.
Factors influencing the desire to provide MS patient care in clinical practice among physiatrists.
Genetic factors and multiple sclerosis in the Moroccan population: A role for HLA class II.
New Strategies in the Management of Guillain-Barré Syndrome.
Burden of disease in multiple sclerosis patients with spasticity in Germany: mobility improvement study (Move I).
Primary progressive multiple sclerosis: progress and challenges.
Iron accumulation in multiple sclerosis: an early pathogenic event.
Genome-wide association studies: will we ever predict susceptibility to multiple sclerosis through genetics?
Cerebrospinal fluid interleukin-6 and glial fibrillary acidic protein levels are increased during initial neuromyelitis optica attacks.
Modelling the Cost Effectiveness of Disease-Modifying Treatments for Multiple Sclerosis : Issues to Consider.
Natalizumab and the development of extensive brain lesions in neuromyelitis optica.
State vocational rehabilitation services and employment in multiple sclerosis.
Conference Scene: Regulatory cells in autoimmunity: analyzing and moderating function.
[Therapeutic options for autoimmune encephalomyelitis].
Fatigue in multiple sclerosis is closely related to sleep disorders: a polysomnographic cross-sectional study.
Pages
« first
‹ previous
…
460
461
462
463
464
465
466
467
468
…
next ›
last »